Calendar

Week of Sep 15, 2025

Sep 18, 2025grant346d agoUNIVERSITY OF MARYLAND BALTIMORE — Investigation of neuraminidase as a target antigen for a universal influenza ...

AI grant. $42,452. PI: Cosette Schneider

full page →nih reporter ↗

Sep 18, 2025grant346d agoUnknown institution — SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].

DA grant. $9,000

full page →nih reporter ↗

Sep 18, 2025grant346d agoUnknown institution — SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]....

DA grant. $2,500

full page →nih reporter ↗

Sep 19, 2025approval345d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗

Sep 19, 2025approval345d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗

Sep 19, 2025approval345d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Sep 19, 2025approval345d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Sep 19, 2025approval345d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Sep 19, 2025approval345d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Sep 19, 2025approval345d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →guselkumab →fda approvals ↗

Sep 19, 2025approval345d agoLEUPROLIDE ACETATE — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Sep 19, 2025approval345d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: MEITHEAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗

Sep 19, 2025approval345d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: MEITHEAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗

Sep 19, 2025approval345d agoLOPERAMIDE HYDROCHLORIDE — FDA approvalLOPERAMIDE HYDROCHLORIDE

Sponsor: BIONPHARMA. Form: SOLUTION. Route: ORAL

full page →LOPERAMIDE HYDROCHLORIDE →fda approvals ↗

Sep 19, 2025approval345d agoAMBRISENTAN — FDA approvalAMBRISENTAN

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →AMBRISENTAN →fda approvals ↗

Sep 19, 2025approval345d agoFORZINITY (ELAMIPRETIDE HYDROCHLORIDE) — FDA approvalelamipretide hydrochloride

Sponsor: STEALTH BIOTHERAPS. Form: SOLUTION. Route: SUBCUTANEOUS

full page →elamipretide hydrochloride →fda approvals ↗

Sep 19, 2025approval345d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Sep 19, 2025approval345d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Sep 19, 2025approval345d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Sep 19, 2025approval345d agoPROGESTERONE — FDA approvalPROGESTERONE

Sponsor: XIROMED. Form: INSERT. Route: VAGINAL

full page →PROGESTERONE →fda approvals ↗

Sep 19, 2025approval345d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 19, 2025approval345d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 19, 2025approval345d agoLOSARTAN POTASSIUM — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 19, 2025approval345d agoPROPOFOL — FDA approvalPROPOFOL

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PROPOFOL →fda approvals ↗

Sep 19, 2025grant345d agoEMORY UNIVERSITY — SMILE (Sickle Cell Disease Microbiologic and Immunologic Links to Health)Emory University

HL grant. $794,661. PI: Matthew Z Anderson

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF HOUSTON — Mechanical and non-mechanical contributions to chronic neck, shoulder, arm, a...

AR grant. $365,339. PI: Stacey Lynn Gorniak

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF ARIZONA — Skeletal Maturity and Segmental Spinal Mobility Predict Successful Vertebral ...

AR grant. $616,238. PI: Melanie Emily Boeyer

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF WISCONSIN-MADISON — Re-evaluating the Duration in Children of TB Treatment (REDUCE TB): A Phase 2...

AI grant. $164,241. PI: Anthony Joseph Garcia-Prats

full page →nih reporter ↗

Sep 19, 2025grant345d agoCINCINNATI CHILDRENS HOSP MED CTR — Improving Medication Adherence using an Adaptive mHealth Intervention in Adol...

HL grant. $731,130. PI: Rachelle R. Ramsey

full page →nih reporter ↗

Sep 19, 2025grant345d agoBRIGHAM AND WOMEN'S HOSPITAL — Characterizing Biological Aging for Heart and Lung Diseases Using Multi-omics...Brigham and Women's Hospital

HL grant. $177,120. PI: Yulu Chen

full page →nih reporter ↗

Sep 19, 2025grant345d agoGRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY — Streamlined Treatment and Evidence-based Adolescent counseling and Medication...

MH grant. $1,057,586. PI: Philip Kreniske

full page →nih reporter ↗

Sep 19, 2025grant345d agoO2M TECHNOLOGIES, LLC — Advanced Imaging Methods in Pulse EPR

CA grant. $1,164,814. PI: Boris Epel

full page →nih reporter ↗

Sep 19, 2025grant345d agoMASSACHUSETTS GENERAL HOSPITAL — Empowering cancer detection and monitoring with CampEx - CRISPR-accelerated m...Massachusetts General Hospital

CA grant. $2,855,619. PI: Cesar M Castro

full page →nih reporter ↗

Sep 19, 2025grant345d agoOREGON HEALTH & SCIENCE UNIVERSITY — Pediatric Prehospital Ventilation Trial (Pedi-VENT)

HL grant. $816,119. PI: Matthew Lee Hansen

full page →nih reporter ↗

Sep 19, 2025grant345d agoNORTHEASTERN UNIVERSITY — Causal Machine Learning Methods to Study Individual Vaccine Efficacy Using Mu...

AI grant. $189,790. PI: Larry Han

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Neurocognitive responses to social threat: Links to day-to-day connectedness ...

MH grant. $185,552. PI: Kiera M James

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Machine Learning Prediction of Persistent Adverse Mental Health Outcomes for ...University of Southern California

MH grant. $817,597. PI: Amber M. Angell

full page →nih reporter ↗

Sep 19, 2025grant345d agoFRED HUTCHINSON CANCER CENTER — Comprehensive Characterization of the T-cell Response to KSHV to Enable Speci...

CA grant. $4,234,248. PI: Edus Houston Warren

full page →nih reporter ↗

Sep 19, 2025grant345d agoOKLAHOMA MEDICAL RESEARCH FOUNDATION — Aging, Sex Bias, and CD8 T Cell Exhaustion in Salivary Gland Inflammation

DE grant. $468,875. PI: HARINI BAGAVANT

full page →nih reporter ↗

Sep 19, 2025grant345d agoTUFTS UNIVERSITY BOSTON — Microbial Determinants of Excessive Inflammation and Severe Lyme Disease

AI grant. $3,315,179. PI: Klemen Strle

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Analysis of high dimensional genomic dataset to reveal mechanistic insights o...

DE grant. $1,899,042. PI: Heath Devin Skinner

full page →nih reporter ↗

Sep 19, 2025grant345d agoEMORY UNIVERSITY — A Phase 2b randomized open label trial to assess the quality and balance of d...Emory University

AI grant. $578,157. PI: Matthew Collins

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF PENNSYLVANIA — Decoding Nuclear Mechanosignaling and Epigenetic Mediators of Mechanical Memo...University of Pennsylvania

HL grant. $169,020. PI: Nesrine Bouhrira

full page →nih reporter ↗

Sep 19, 2025grant345d agoPRINCETON UNIVERSITY — Multiscale coordination of planar cell polarity

AR grant. $1,372,009. PI: Danelle N Devenport

full page →nih reporter ↗

Sep 19, 2025grant345d agoSTANFORD UNIVERSITY — A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blo...Stanford University

HL grant. $773,843. PI: Han Zhu

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB ...University of California San Francisco

AI grant. $323,255. PI: Adithya Cattamanchi

full page →nih reporter ↗

Sep 19, 2025grant345d agoINDIANA UNIVERSITY INDIANAPOLIS — Targeting the Unfolded Protein Response Master Regulator BiP to Induce CellDe...

CA grant. $280,638. PI: Zainul S Hasanali

full page →nih reporter ↗

Sep 19, 2025grant345d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Core-002

AR grant. $104,040. PI: Gwendolyn A Sowa

full page →nih reporter ↗

Sep 19, 2025grant345d agoCINCINNATI CHILDRENS HOSP MED CTR — Biopsychosocial determinants of pediatric-onset chronic musculoskeletal pain

AR grant. $1,955,201. PI: Michael P Jankowski

full page →nih reporter ↗

Sep 19, 2025grant345d agoSEATTLE CHILDREN'S HOSPITAL — Leveraging a National Pediatric Health Learning System for Phenotyping Pediat...Seattle Children's Hospital

AR grant. $2,319,459. PI: Tonya M Palermo

full page →nih reporter ↗

← prev

page 356 of 475

Week of Sep 15, 2025